8. For a certain product 5,4% of all drug-event-combinations are related to a
specific event.
However only 1,4% of all drug-event combinations are related to this event.
This drug-event combination appears 3,8 times more than would be expected.
pharmaSOL All Rights Reserved Slide 8
Event All other
events
Percentage PRR
Medicinal Product 52 958 5,4%
3,8
All other medicinal products 691 50.000 1,4%
9. Strengths
o Observation in Real-Time
o Case Details
o Availability of Source Data
o Full narrative
Possible Weaknesses
o Product specific volume
o Total case volume (background)
o Non-diverse product portfolio
o Mix of new and mature products
o Different indications
pharmaSOL All Rights Reserved Slide 9
10. FDA AERS (USA)
o since 1968, focus on US data, released quarterly
WHO Vigibase
o since 1968, data from regulatory agencies worldwide, released quarterly
PMDA (Japan)
o Recently released, focus on Japan
Eudravigilance
o EMA intends to publish data in the future
o Focus on European Economic Area (EEA)
pharmaSOL All Rights Reserved Slide 10
11. Strengths
o Size and Diversity of public databases
o Information on generic competition
o Ability to detect Class Effects
Possible Weaknesses
o Case details
o Duplicates
o Time delay (ca. 6 months)
pharmaSOL All Rights Reserved Slide 11
12. pharmaSOL All Rights Reserved Slide 12
Big
Pharma
Mid-sized
Pharma
Small
Pharma
Need High Medium Medium
Suitable company
dataset
Yes Maybe No
Quantitative Signal
Detection
In use Partly No
13. pharmaSOL All Rights Reserved Slide 13
Company
dataset
too small
Likely to be
dominated
by few products
or indication areas
Public Data
available with
a time delay
14. Spiking: Merge of Company Data with Public Data
o Information related to company product is removed from public
dataset
o Identifier used: compound name
Company data is injected.
pharmaSOL All Rights Reserved Slide 14
Public Data
Company
Data
Company
Data within
Public Data
15. pharmaSOL All Rights Reserved Slide 15
Risks
If product has generic
competition, information is
lost.
Benefits
Up-to-date with company
data
Case Details from
company data
Broad background from
public dataset